Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.480
+0.010 (0.40%)
At close: Dec 5, 2025, 4:00 PM EST
2.570
+0.090 (3.63%)
After-hours: Dec 5, 2025, 6:51 PM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $15.26 million as of December 5, 2025. Its market cap has decreased by -50.94% in one year.
Market Cap
15.26M
Enterprise Value
5.21M
1-Year Change
-50.94%
Ranking
Category
Stock Price
$2.48
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $15.26M, a decrease of -97.58%. That is a compound annual growth rate of -54.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 15.20M | -55.46% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |